Editorial: venlafaxine for functional chest pain: hope or hype?
Tutuian
Radu
R
D000328:Adult; D002637:Chest Pain / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology / Q000523:psychology; D018592:Cross-Over Studies; D003511:Cyclohexanols / Q000008:administration & dosage / Q000627:therapeutic use*; D004311:Double-Blind Method; D004935:Esophageal Diseases / Q000150:complications* / Q000503:physiopathology / Q000523:psychology; D050782:Esophageal pH Monitoring; D005260:Female; D006801:Humans; D008297:Male; D008365:Manometry; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D017367:Selective Serotonin Reuptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D012720:Severity of Illness Index; D012737:Sex Factors; D000069470:Venlafaxine Hydrochloride
D003511:Cyclohexanols; D017367:Selective Serotonin Reuptake Inhibitors; D000069470:Venlafaxine Hydrochloride